This gene-based therapeutics stock could nearly triple, analysts say Leave a Comment / Uncategorized / By The Survivor Three firms initiated coverage of the the gene-based therapeutics company.
Wells Fargo double upgrades this oil and gas stock on improved capital efficiency and Permian productivity
